Alyeska Investment Group L.P. reduced its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 39.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,579,334 shares of the real estate investment trust's stock after selling 1,012,439 shares during the period. Alyeska Investment Group L.P. owned about 0.23% of Healthpeak Properties worth $31,934,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also bought and sold shares of DOC. TCTC Holdings LLC raised its holdings in Healthpeak Properties by 124.3% during the 1st quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust's stock valued at $27,000 after buying an additional 751 shares during the last quarter. Brooklyn Investment Group lifted its position in Healthpeak Properties by 198.9% during the first quarter. Brooklyn Investment Group now owns 1,312 shares of the real estate investment trust's stock valued at $27,000 after buying an additional 873 shares during the period. Future Financial Wealth Managment LLC purchased a new position in Healthpeak Properties during the first quarter valued at $30,000. S.A. Mason LLC increased its holdings in shares of Healthpeak Properties by 160.9% during the first quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust's stock valued at $30,000 after acquiring an additional 925 shares in the last quarter. Finally, Dagco Inc. bought a new position in shares of Healthpeak Properties during the first quarter valued at $30,000. 93.57% of the stock is currently owned by institutional investors.
Insider Transactions at Healthpeak Properties
In other Healthpeak Properties news, CEO Scott M. Brinker bought 1,490 shares of the business's stock in a transaction on Monday, August 4th. The stock was bought at an average price of $16.83 per share, with a total value of $25,076.70. Following the completion of the purchase, the chief executive officer directly owned 211,906 shares in the company, valued at $3,566,377.98. The trade was a 0.71% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders acquired a total of 8,783 shares of company stock worth $150,129 over the last ninety days. 0.23% of the stock is owned by company insiders.
Healthpeak Properties Stock Down 1.2%
Healthpeak Properties stock opened at $17.74 on Thursday. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.06. Healthpeak Properties, Inc. has a 52 week low of $16.63 and a 52 week high of $23.26. The business's 50-day moving average price is $17.72 and its 200 day moving average price is $18.27. The firm has a market cap of $12.32 billion, a price-to-earnings ratio of 73.90, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07.
Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its quarterly earnings data on Thursday, July 24th. The real estate investment trust reported $0.46 EPS for the quarter, meeting the consensus estimate of $0.46. The company had revenue of $694.35 million for the quarter, compared to analyst estimates of $697.14 million. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.Healthpeak Properties's quarterly revenue was down .2% compared to the same quarter last year. During the same period last year, the company earned $0.45 earnings per share. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, sell-side analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.
Healthpeak Properties Dividend Announcement
The firm also recently announced a monthly dividend, which was paid on Friday, August 29th. Shareholders of record on Monday, August 18th were paid a dividend of $0.1017 per share. The ex-dividend date of this dividend was Monday, August 18th. This represents a c) annualized dividend and a yield of 6.9%. Healthpeak Properties's dividend payout ratio (DPR) is 508.33%.
Analysts Set New Price Targets
Several research firms recently commented on DOC. Wall Street Zen downgraded Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Monday, July 7th. Morgan Stanley lowered their price objective on Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating on the stock in a research report on Friday, August 22nd. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and set a $18.00 price objective (down from $28.00) on shares of Healthpeak Properties in a research report on Wednesday, August 20th. Scotiabank cut Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and lowered their price target for the stock from $21.00 to $19.00 in a report on Tuesday, July 29th. Finally, Robert W. Baird set a $21.00 price target on Healthpeak Properties and gave the stock an "outperform" rating in a report on Wednesday, July 30th. Seven analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $21.50.
Read Our Latest Research Report on Healthpeak Properties
Healthpeak Properties Company Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.